Long-term Effects of Hydroxyurea in Psoriasis
- 9 December 1972
- Vol. 4 (5840) , 585-587
- https://doi.org/10.1136/bmj.4.5840.585
Abstract
Hydroxyurea is an effective treatment for psoriasis but consistently produces macrocytosis in peripheral blood with a fall in haemoglobin levels and white cell counts. In this long-term study of 16 patients anaemia and leukopenia have proved frequent and troublesome side effects requiring discontinuance of treatment in many cases. In view of these findings hydroxyurea cannot be recommended as the drug of first choice even for treating severe and intractable psoriasis, and it is our opinion that methotrexate is safer and at least as effective in these circumstances. The clearest indications for the use of hydroxyurea appear to be in life-ruining psoriasis when methotrexate treatment has either failed or is contraindicated because of liver damage. A great deal more investigative work is required before these indications can be generally extended.Keywords
This publication has 11 references indexed in Scilit:
- HYDROXYUREA: A NEW ANTIMETABOLITE IN THE TREATMENT OF PSORIASISBritish Journal of Dermatology, 1971
- HYDROXYUREA IN THE TREATMENT OF PUSTULAR PSORIASISBritish Journal of Dermatology, 1971
- Liver Damage due to Methotrexate in Patients with PsoriasisBMJ, 1971
- Comparison of cytotoxicity of hydroxyurea in normal and rapidly proliferating epidermis and small intestine in mice.1971
- Hydroxyurea. A new treatment for psoriasisArchives of Dermatology, 1970
- Some hazards of methotrexate treatment of psoriasis.1970
- HYDROXYUREA IN THE TREATMENT OF REFRACTORY PSORIASISThe Lancet, 1969
- HYDROXYUREA - EFFECTS ON CHINESE HAMSTER CELLS GROWN IN CULTURE1967
- DISTRIBUTION EXCRETION AND METABOLISM OF HYDROXYUREA-C141965
- STUDY OF SERUM B12 AND FOLATE IN PATIENTS TREATED WITH HYDROXYUREA (NSC-32065).1964